{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:15:08Z","timestamp":1707524108507},"reference-count":19,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,6,15]]},"DOI":"10.7759\/cureus.8637","type":"journal-article","created":{"date-parts":[[2020,6,15]],"date-time":"2020-06-15T16:04:44Z","timestamp":1592237084000},"source":"Crossref","is-referenced-by-count":0,"title":["A Rare Case of Missing Primary in Metastatic Renal Cell Carcinoma"],"prefix":"10.7759","author":[{"given":"Ankita","family":"Kapoor","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikhil","family":"Khushalani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shipra","family":"Gandhi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.4065\/72.10.935","article-title":"Renal cell carcinoma: diagnosis based on metastatic manifestations","volume":"72","author":"Wahner-Roedler DL","year":"1997","unstructured":"Wahner-Roedler DL, Sebo TJ. Renal cell carcinoma: diagnosis based on metastatic manifestations. Mayo Clin Proc. 1997, 72:935-941. 10.4065\/72.10.935","journal-title":"Mayo Clin Proc"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(20000801)89:3<604::AID-CNCR16>3.0.CO;2-Q","article-title":"Prognostic utility of the recently recommended histologic classification and revised TNM staging system of renal cell carcinoma: a Swiss experience with 588 tumors","volume":"89","author":"Moch H","year":"2000","unstructured":"Moch H, Gasser T, Amin MB, Torhorst J, Sauter G, Mihatsch MJ. Prognostic utility of the recently recommended histologic classification and revised TNM staging system of renal cell carcinoma: a Swiss experience with 588 tumors. Cancer. 2000, 89:604-614. 10.1002\/1097-0142(20000801)89:3&lt;604::AID-CNCR16&gt;3.0.CO;2-Q","journal-title":"Cancer"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1111\/bju.12950","article-title":"Renal cell cancer histological subtype distribution differs by race and sex","volume":"117","author":"Lipworth L","year":"2016","unstructured":"Lipworth L, Morgans AK, Edwards TL, et al.. Renal cell cancer histological subtype distribution differs by race and sex. BJU Int. 2016, 117:260-265. 10.1111\/bju.12950","journal-title":"BJU Int"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1601333","article-title":"Systemic therapy for metastatic renal-cell carcinoma","volume":"376","author":"Choueiri TK","year":"2017","unstructured":"Choueiri TK, Motzer RJ. Systemic therapy for metastatic renal-cell carcinoma. N Engl J Med. 2017, 376:354-366. 10.1056\/NEJMra1601333","journal-title":"N Engl J Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.3880175","article-title":"Cytokeratin 7 and cytokeratin 20 expression in epithelial neoplasms: a survey of 435 cases","volume":"13","author":"Chu P","year":"2000","unstructured":"Chu P, Wu E, Weiss LM. Cytokeratin 7 and cytokeratin 20 expression in epithelial neoplasms: a survey of 435 cases. Mod Pathol. 2000, 13:962-972. 10.1038\/modpathol.3880175","journal-title":"Mod Pathol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1155\/2010\/698014","article-title":"Late simultaneous metastasis of renal cell carcinoma to the submandibular and thyroid glands seven years after radical nephrectomy","author":"Miah MS","year":"2010","unstructured":"Miah MS, White SJ, Oommen G, Birney E, Majumdar S. Late simultaneous metastasis of renal cell carcinoma to the submandibular and thyroid glands seven years after radical nephrectomy. Int J Otolaryngol. 2010, 1-4. 10.1155\/2010\/698014","journal-title":"Int J Otolaryngol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdr362","article-title":"Distribution of metastatic sites in renal cell carcinoma: a population-based analysis","volume":"23","author":"Bianchi M","year":"2012","unstructured":"Bianchi M, Sun M, Jeldres C, et al.. Distribution of metastatic sites in renal cell carcinoma: a population-based analysis. Ann Oncol. 2012, 23:973-980. 10.1093\/annonc\/mdr362","journal-title":"Ann Oncol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1136\/thx.21.5.437","article-title":"Metastatic carcinoma of the pleura","volume":"21","author":"Meyer PC","year":"1966","unstructured":"Meyer PC. Metastatic carcinoma of the pleura. Thorax. 1966, 21:437-443. 10.1136\/thx.21.5.437","journal-title":"Thorax"},{"key":"ref9","article-title":"Renal cell carcinoma, primary lesion which was not easily identified: report of two cases [Article in Japanese]","volume":"31","author":"Kawakita M","year":"1985","unstructured":"Kawakita M, Kawamura J, Hida S, Ooishi K, Okada K, Yoshida O. Renal cell carcinoma, primary lesion which was not easily identified: report of two cases [Article in Japanese]. Hinyokika Kiyo. 1985, 31:463-473.","journal-title":"Hinyokika Kiyo"},{"key":"ref10","article-title":"Renal cell carcinoma metastatic to the skin","volume":"20","author":"Koga S","year":"2000","unstructured":"Koga S, Tsuda S, Nishikido M, Matsuya F, Saito Y, Kanetake H. Renal cell carcinoma metastatic to the skin. Anticancer Res. 2000, 20:1939-1940.","journal-title":"Anticancer Res"},{"key":"ref11","doi-asserted-by":"crossref","DOI":"10.1242\/dev.119.3.711","article-title":"Pax-2 is required for mesenchyme-to-epithelium conversion during kidney development","volume":"119","author":"Rothenpieler UW","year":"1993","unstructured":"Rothenpieler UW, Dressler GR. Pax-2 is required for mesenchyme-to-epithelium conversion during kidney development. Development. 1993, 119:711-720.","journal-title":"Development"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.jjco.a039282","article-title":"Papillary cystic tumor of the pancreas: an immunohistochemical and ultrastructural study of 14 patients","volume":"19","author":"Yamaguchi K","year":"1989","unstructured":"Yamaguchi K, Miyagahara T, Tsuneyoshi M, et al.. Papillary cystic tumor of the pancreas: an immunohistochemical and ultrastructural study of 14 patients. Jpn J Clin Oncol. 1989, 19:102-111. 10.1093\/oxfordjournals.jjco.a039282","journal-title":"Jpn J Clin Oncol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2002.11.123","article-title":"Treatment outcome and survival associated with metastatic renal cell carcinoma of non-clear-cell histology","volume":"20","author":"Motzer RJ","year":"2002","unstructured":"Motzer RJ, Bacik J, Mariani T, Russo P, Mazumdar M, Reuter V. Treatment outcome and survival associated with metastatic renal cell carcinoma of non-clear-cell histology. J Clin Oncol. 2002, 20:2376-2381. 10.1200\/JCO.2002.11.123","journal-title":"J Clin Oncol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.22340","article-title":"Treatment outcome for metastatic papillary renal cell carcinoma patients","volume":"107","author":"Ronnen EA","year":"2006","unstructured":"Ronnen EA, Kondagunta GV, Ishill N, et al.. Treatment outcome for metastatic papillary renal cell carcinoma patients. Cancer. 2006, 107:2617-2621. 10.1002\/cncr.22340","journal-title":"Cancer"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.3322\/canjclin.57.2.112","article-title":"Recent progress in the management of advanced renal cell carcinoma","volume":"57","author":"Garcia JA","year":"2007","unstructured":"Garcia JA, Rini BI. Recent progress in the management of advanced renal cell carcinoma. CA Cancer J Clin. 2007, 57:112-125. 10.3322\/canjclin.57.2.112","journal-title":"CA Cancer J Clin"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.2174\/157488411797189398","article-title":"Emerging targeted therapies in metastatic renal cell carcinoma","volume":"6","author":"Matrana MR","year":"2011","unstructured":"Matrana MR, Atkinson B, Jonasch E, Tannir NM. Emerging targeted therapies in metastatic renal cell carcinoma. Curr Clin Pharmacol. 2011, 6:189-198. 10.2174\/157488411797189398","journal-title":"Curr Clin Pharmacol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2015.10.049","article-title":"Everolimus versus sunitinib prospective evaluation in metastatic non-clear cell renal cell carcinoma (ESPN): a randomized multicenter phase 2 trial","volume":"69","author":"Tannir NM","year":"2016","unstructured":"Tannir NM, Jonasch E, Albiges L, et al.. Everolimus versus sunitinib prospective evaluation in metastatic non-clear cell renal cell carcinoma (ESPN): a randomized multicenter phase 2 trial. Eur Urol. 2016, 69:866-874. 10.1016\/j.eururo.2015.10.049","journal-title":"Eur Urol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2017.35.15_suppl.4586","article-title":"Nivolumab treatment for patients with non-clear cell renal cell carcinoma: a multicenter retrospective analysis","volume":"35","author":"Koshkin VS","year":"2017","unstructured":"Koshkin VS, Barata PC, Vogelzang NJ, et al.. Nivolumab treatment for patients with non-clear cell renal cell carcinoma: a multicenter retrospective analysis. J Clin Oncol. 2017, 35:4586-4586. 10.1200\/JCO.2017.35.15_suppl.4586","journal-title":"J Clin Oncol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdz056","article-title":"Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"30","author":"Escudier B","year":"2019","unstructured":"Escudier B, Porta C, Schmidinger M, et al.. Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2019, 30:706-720. 10.1093\/annonc\/mdz056","journal-title":"Ann Oncol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/31668-a-rare-case-of-missing-primary-in-metastatic-renal-cell-carcinoma","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:23:19Z","timestamp":1707506599000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/31668-a-rare-case-of-missing-primary-in-metastatic-renal-cell-carcinoma"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,15]]},"references-count":19,"URL":"https:\/\/doi.org\/10.7759\/cureus.8637","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6,15]]}}}